PatternsRadar
Sign in

WANBURYWanbury Limited

NSE
179.37INR-2.29 (-1.26%)Close · 20 Nov 2026
4 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹627 CrMarket cap
—P/E (TTM)
50.8%Delivery

Filings & corporate actions

74 results filed
CSV
Next results · Q3 FY27
Expected 24 Jan 2027 – 15 Feb 2027
Estimate: filed 24–46 days after quarter end, last 5 times
2026
  • 4 NovresultsResults · Q2 FY27 · consolidated and standalone-3.2%NSE
  • 21 OctshareholdingShareholding · 30 Sept 2026+0.9%NSE
  • 11 AugresultsResults · Q1 FY27 · standalone+3.3%NSE
  • 17 JulshareholdingShareholding · 30 Jun 2026-3.2%NSE
  • 29 MayresultsResults · Q4 FY26 · standalone-13.6%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026+0.8%NSE
  • 5 FebresultsResults · Q3 FY26 · standalone-5.8%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025-6.2%NSE

Reaction to results · all yearsrose on day 0 in 26 of 75 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY274 Nov 2026-3.2%+3.9%—1.9×
Q1 FY2711 Aug 2026+3.3%+6.0%-3.8%4.7×
Q4 FY2629 May 2026-13.6%-18.2%-9.0%7.7×
Q3 FY265 Feb 2026-5.8%-2.2%-5.9%0.9×
Q2 FY2613 Nov 2025-3.4%-7.8%-4.7%1.3×
Q1 FY264 Aug 2025-2.4%-7.0%+2.0%2.3×
Q4 FY2515 May 2025+9.8%+3.6%+12.5%17.6×
Q3 FY2512 Feb 2025+1.6%-6.7%-7.9%2.9×
Q2 FY2514 Nov 2024-4.0%+0.4%+39.6%0.8×
Q1 FY2513 Aug 2024-2.9%+13.6%+34.6%1.2×
Q4 FY2418 May 2024-5.0%-10.1%-2.8%5.6×
Q3 FY2424 Jan 2024+0.2%+6.0%+11.5%3.3×
Q2 FY2420 Oct 2023+2.0%+3.9%+4.5%3.3×
Q1 FY2411 Aug 2023+2.0%+8.0%+17.2%0.3×
Q4 FY237 Jul 2023-3.6%-11.5%-11.5%1.9×
Q3 FY2315 Feb 2023-4.0%-8.7%-21.6%0.9×
Q2 FY2329 Nov 2022+3.5%-2.3%-9.5%1.3×
Q1 FY2310 Aug 2022-5.0%-14.4%+0.5%1.1×
Q4 FY2223 Jun 2022+4.9%+8.9%+7.4%0.1×
Q3 FY229 Feb 2022-5.0%-15.9%-25.9%0.5×
Q2 FY2225 Nov 2021-3.2%+7.2%+11.0%0.9×
Q1 FY2220 Oct 2021-3.3%-16.5%-11.0%0.9×
Q4 FY2129 Jun 2021-5.0%-9.7%-8.7%0.4×
Q3 FY2112 Feb 2021+5.0%+26.0%+28.0%2.9×
Q2 FY2112 Nov 2020+0.4%-0.1%+19.2%1.5×
Q1 FY2111 Sept 2020-4.6%-4.0%-5.5%1.3×
Q4 FY2022 Jul 2020-4.9%-13.4%+32.7%4.3×
Q3 FY2015 Feb 2020+4.8%+32.8%-14.9%31.4×
Q2 FY2013 Nov 2019+4.9%+32.6%+47.3%2.4×
Q1 FY2014 Aug 2019-4.2%-8.3%-8.0%1.9×
Q4 FY1914 Aug 2019-4.2%-8.3%-8.0%1.9×
Q3 FY191 Mar 2019+4.3%+11.6%+26.9%1.0×
Q2 FY1922 Nov 2018-4.0%+4.0%-5.5%0.4×
Q4 FY1830 Aug 2018-1.8%+5.2%-16.7%0.7×
Q1 FY1930 Aug 2018-1.8%+5.2%-16.7%0.7×
Q3 FY1815 Feb 2018-1.6%-2.5%-12.1%1.1×
Q2 FY1812 Dec 2017+4.9%+4.7%+22.0%4.0×
Q1 FY1813 Sept 2017-1.8%-2.6%-3.6%3.2×
Q4 FY1717 Jun 2017-3.3%-2.9%+2.6%0.5×
Q3 FY1715 Feb 2017-4.9%-7.4%-20.0%0.1×
Q2 FY172 Dec 2016+4.9%+33.5%+41.4%0.4×
Q1 FY1713 Aug 2016-4.9%-13.6%-8.4%0.1×
Q4 FY1619 May 2016-3.2%-10.3%-8.0%0.8×
Q3 FY1613 Feb 2016-4.9%-16.1%-5.8%1.9×
Q2 FY167 Nov 2015-2.5%-5.8%-2.5%2.5×
Q1 FY1616 Aug 2015+3.3%-10.0%-15.8%1.6×
Q4 FY1522 May 2015-5.0%-18.7%-3.4%0.2×
Q3 FY1519 Feb 2015+4.9%+19.0%+74.3%0.5×
Q4 FY1416 May 2014+2.5%+11.6%+28.2%2.8×
Q3 FY1426 Feb 2014-1.3%+2.7%-4.2%0.5×
Q2 FY1422 Nov 2013-3.0%+1.1%+0.8%0.7×
Q1 FY1416 Aug 2013-6.6%-8.9%-0.5%0.9×
Q4 FY1312 Jun 20130.0%-3.2%-0.2%0.1×
Q3 FY1311 Feb 2013-3.9%-12.8%-5.5%0.3×
Q2 FY135 Nov 2012-2.7%-4.4%+2.9%0.2×
Q1 FY136 Aug 20120.0%+4.4%-8.3%1.1×
Q4 FY1229 May 2012+1.5%-5.5%+2.6%0.2×
Q3 FY1210 Feb 2012-9.2%-14.1%-25.6%1.5×
Q2 FY128 Nov 2011+0.2%-13.2%-7.7%4.1×
Q1 FY1218 Aug 2011-1.6%-4.7%+8.1%1.1×
Q4 FY117 Jun 2011-1.7%-4.4%-10.2%0.1×
Q3 FY112 Feb 2011-10.7%-29.4%-24.7%3.0×
Q2 FY1129 Oct 2010-5.6%-6.3%-32.8%1.3×
Q1 FY1112 Aug 2010-3.8%-4.7%-2.4%3.9×
Q4 FY1028 May 2010+15.4%+11.1%+20.9%6.0×
Q3 FY1022 Jan 2010-2.6%-1.3%-6.7%0.7×
Q2 FY1028 Oct 2009-5.0%-23.0%-13.2%0.5×
Q1 FY1027 Jul 2009+19.3%+35.9%+53.1%5.8×
Q4 FY0930 Jun 2009-3.4%-10.8%+11.4%0.3×
Q3 FY0930 Jan 2009-2.2%-0.3%-10.5%0.2×
Q4 FY0827 Jun 2008+0.6%+2.8%+2.3%0.4×
Q3 FY0830 Jan 2008+2.5%+12.9%+0.8%0.4×
Q2 FY0831 Oct 2007-0.2%-2.5%-4.5%1.5×
Q1 FY0830 Jul 2007+0.2%+6.8%-0.4%0.1×
Q4 FY0729 Jun 2007+14.9%+10.3%+10.0%26.0×
Average-0.9%-0.9%+1.9%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ—
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open181.98
Day range178.20 – 184.48
52-week range161.50 – 358.85
From 52w high-50.0%
RSI (14)41.0
ATR (14)11.00
Volume1.49L
Avg volume (20D)2.99L
Rel volume0.50×
Volatility (1Y)55.0%
Turnover₹2.7Cr
Traded value (NSE)₹2.7Cr
VWAP181.17
SMA 50 / 200199.90 / 249.17
Price band20%

Delivery percentage

Latest · 20 Nov 202650.8%
20-day avg47.5%
1-year avg62.7%
Percentile (own history)9th
Range13.5–100.0%
Sessions2,013

Over the last 20 sessions WANBURY settled 47.5% of its traded quantity, which is above average for an NSE equity. Its one-year average is 62.7%, so recent sessions are running 15.2 points lower than usual. The latest session ranks higher than 9% of the 2,013 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders—
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy100 days ago

Performance returns

1D1W1M3M6M1Y
Price-1.26%-7.28%-3.45%-33.20%-36.62%-25.42%

Valuation

Market cap₹627 Cr
Market cap (NSE)₹627 Cr
Free-float cap₹358 Cr
P/E (TTM)—
P/E (NSE)12.9
EPS (TTM)—
P/B4.0
Net margin (TTM)—
Other income / PBT—
ROE—
Debt / equity1.43
Shares outstanding3.50Cr
Listed29 Jan 2007

Ownership

Promoter42.98%
Promoter Δ QoQ-0.04 pp
Public57.02%
FII—
DII—
Pledged—

Quarterly results · consolidated

Q3 FY25Q4 FY25Q1 FY26Q2 FY27
Revenue (₹ Cr)133.5172.0163.2182.9
YoY chg-8.3%+23.4%+24.5%—
Net profit (₹ Cr)1.220.313.58.5
YoY chg-88.1%-39.8%+1200.4%—
Net margin0.9%11.8%8.3%4.7%
EPS0.705.983.952.43

Shareholding over time

By quarter

30 Sept 2026 · promoter 42.98% · public 57.02%
30 Sept 2021: promoter 39.90%31 Dec 2021: promoter 39.89%31 Mar 2022: promoter 39.89%30 Jun 2022: promoter 39.85%30 Sept 2022: promoter 39.85%31 Dec 2022: promoter 39.84%31 Mar 2023: promoter 39.84%30 Jun 2023: promoter 39.84%30 Sept 2023: promoter 39.80%31 Dec 2023: promoter 39.79%31 Mar 2024: promoter 39.79%30 Jun 2024: promoter 39.79%30 Sept 2024: promoter 39.77%31 Dec 2024: promoter 39.76%31 Mar 2025: promoter 39.76%30 Jun 2025: promoter 39.63%18 Sept 2025: promoter 43.09%30 Sept 2025: promoter 43.09%31 Dec 2025: promoter 43.07%31 Mar 2026: promoter 43.02%30 Jun 2026: promoter 43.02%30 Sept 2026: promoter 42.98%
2021-092026-09
  • Promoter
  • Public and others
Promoter
42.98%
Public
57.02%
Promoter change
-0.04 pp
Filed
21 Oct 2026
FII
—
DII
—
Promoter pledged
—

Who the public is

Mutual funds
—
Insurance
—
FPI
—
Retail ≤ ₹2L
—
HNI > ₹2L
—
NRI
—
Bodies corporate
—
Shareholders
—

Major holders

As of 30 Jun 2026
HolderTypeHolding
EXPERT CHEMICALS (INDIA) PVT LTDPromoter · Corporate34.36%
KINGSBURY INVESTMENTS INCPromoter · Corporate8.65%
SURESH BHATIAIndividual3.11%
AUTHUM INVESTMENT AND INFRASTRUCTURE LIMITEDCorporate2.07%
ZAKI ABBAS NASSERIndividual1.76%
SHARMIN NASSERIndividual1.33%
BASAVA SANKARARAO KOLLIIndividual1.16%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
5
0 open-market of the newest 5
By year

No open-market insider trades among the recent disclosures.

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 6 Oct 2026

CSV
12 of 56 deals
By year
DateDealClientQuantityPriceValue
6 Oct 2026Sell · bulkDHUNSERI VENTURES LIMITED1.97L199.95₹3.9Cr
12 Aug 2026Sell · bulkHRTI PRIVATE LIMITED4.14L251.38₹10.4Cr
12 Aug 2026Buy · bulkHRTI PRIVATE LIMITED2.42L252.40₹6.1Cr
11 Aug 2026Buy · bulkHRTI PRIVATE LIMITED2.17L243.49₹5.3Cr
11 Aug 2026Sell · bulkHRTI PRIVATE LIMITED2.09L245.28₹5.1Cr
14 Jul 2026Sell · bulkJUNOMONETA FINSOL PRIVATE LIMITED3.30L338.14₹11.1Cr
14 Jul 2026Buy · bulkJUNOMONETA FINSOL PRIVATE LIMITED3.25L337.78₹11.0Cr
14 Jul 2026Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED1.76L336.91₹5.9Cr
14 Jul 2026Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED1.76L336.68₹5.9Cr
14 Jul 2026Sell · bulkGRT STRATEGIC VENTURES LLP1.75L338.66₹5.9Cr
14 Jul 2026Sell · bulkSILVERLEAF CAPITAL SERVICES PRIVATE LIMITED1.75L338.92₹5.9Cr
14 Jul 2026Buy · bulkSILVERLEAF CAPITAL SERVICES PRIVATE LIMITED1.75L338.88₹5.9Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026
  • High-low range > 100% in 6 months · since 23 Oct 2026 — One of the criteria NSE’s surveillance watches: high-low range > 100% in 6 months.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY23Q4 FY23AQ1 FY24Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY27
Revenue from operations125.8133.0146.3144.5145.5139.4131.1161.2133.5172.0163.2182.9
Other income0.3(2.1)0.60.80.70.90.91.60.81.80.30.1
Total income126.0130.9146.9145.2146.2140.3132.1162.8134.3173.8163.5183.0
Total expenses129.1129.4141.9138.0135.9132.0131.0154.7133.0154.8149.9170.7
└ Finance costs6.67.55.87.78.37.57.610.110.29.07.56.3
└ Depreciation3.13.13.23.23.33.33.33.33.33.43.64.2
Profit before tax(3.0)0.95.07.210.333.91.08.21.319.113.612.4
Tax expense0.2(0.1)0.3(0.2)(0.0)0.30.00.10.1(1.2)0.13.8
Net profit(3.3)1.04.77.410.333.61.08.01.220.313.58.5
EPS-1.000.801.432.253.1312.750.322.440.766.184.122.44
Net margin-2.61%0.76%3.20%5.10%7.06%24.13%0.79%4.97%0.91%11.78%8.27%4.66%
PBT margin-2.42%0.69%3.41%4.97%7.05%24.32%0.79%5.07%0.97%11.08%8.34%6.76%
Tax rate—-10.34%6.06%-2.45%-0.17%0.80%0.00%1.82%5.76%-6.31%0.85%31.02%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 4 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 H1 FY23FY23H1 FY24FY24H1 FY25FY25H1 FY27
Total assets343.9303.9346.2343.5396.8413.9571.5
Current assets162.7122.2155.0159.3189.6193.4272.1
└ Cash & equivalents1.71.57.23.45.94.18.0
└ Other bank balances3.32.43.42.55.98.82.3
└ Current investments0.00.00.00.00.00.10.0
└ Trade receivables94.068.075.789.4111.5114.2146.1
└ Inventories32.822.035.236.037.637.766.5
Total equity(31.3)(32.8)(22.3)27.938.759.3156.4
└ Attributable to owners(31.3)(32.8)(22.3)27.938.759.3157.0
└ Non-controlling interest——0.0—0.00.0(0.6)
└ Share capital32.732.732.732.732.832.835.0
Borrowings60.964.1105.6110.0175.6173.2223.6
└ Current60.964.110.628.056.812.942.0
└ Non-current0.00.095.082.0118.8160.3181.6
Trade payables199.7148.5161.7162.7137.6138.5135.6
Current liabilities359.8320.4252.6214.1220.0174.6208.2
Total liabilities375.2336.7368.5315.6358.0354.6415.2
Net debt55.960.295.0104.1163.8160.3213.3
Debt / equity———3.944.532.921.43
Current ratio0.450.380.610.740.861.111.31

Cash flow, year to date

 FY22H1 FY23FY23H1 FY24FY24H1 FY25FY25H1 FY27
Operating cash flow37.6(2.5)19.8(6.7)4.0(18.6)26.137.5
└ Capex0.0(5.5)0.00.0(17.4)0.0(49.0)(26.6)
Free cash flow37.6(8.0)19.8(6.7)(13.4)(18.6)(22.9)10.9
Investing cash flow0.6(5.9)(8.8)(11.8)(16.6)(25.6)(51.2)(22.7)
Financing cash flow(25.6)(12.5)(32.0)24.214.646.725.7(8.5)
└ Dividends paid0.00.00.00.00.00.00.00.0
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash12.5(20.8)(21.0)5.71.92.50.76.4

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

WANBURY at a glance

  • WANBURY closed at ₹179.37 on 20 Nov 2026, -1.26% on the day, -25.4% over one year, 50.0% below its 52-week high of ₹358.85.
  • Delivery was 50.8% of traded quantity on 20 Nov 2026, the 9th percentile of its own 2,013 sessions with a reading (20-session average 47.5%, 1-year average 62.7%).
  • Market capitalisation is ₹627 crore, with no positive trailing earnings for a P/E.
  • Q2 FY27 results (consolidated, filed 4 Nov 2026): revenue ₹183 crore, net profit ₹9 crore; the price moved -3.2% on the first session after.
  • Promoters held 42.98% at 30 Sept 2026, down 0.04 percentage points on the previous filing.
  • Q3 FY27 results are expected between 24 Jan 2027 and 15 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE107F01022
SeriesEQ
Listed29 Jan 2007
NSE market cap · 17 Nov 2026₹620 Cr
Free-float market cap (NSE)₹345 Cr
Shares outstanding (NSE)3.50Cr
History from29 Jan 2007
Sessions4,902

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.